|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current assets | |||||||||
| Cash | |||||||||
| Other receivable | |||||||||
| Due from Sponsor | |||||||||
| Cash and cash equivalents | |||||||||
| Short-term investments | |||||||||
| Prepaid expenses and other current assets | |||||||||
| Prepaid expenses | |||||||||
| Total current assets | |||||||||
| Deferred offering costs | |||||||||
| Long-term prepaid insurance | |||||||||
| Marketable securities held in Trust Account | |||||||||
| Property and equipment, net | |||||||||
| Long-term investments | |||||||||
| Intangible assets, net | |||||||||
| Right-of-use assets | |||||||||
| Other assets | |||||||||
| Total Assets | |||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||
| Current liabilities | |||||||||
| Accrued expenses | |||||||||
| Accrued offering costs | |||||||||
| Advance from related party | |||||||||
| Promissory note - related party | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Operating lease liabilities, current | |||||||||
| Finance lease liabilities, current | |||||||||
| Related party advance (Note 12) | |||||||||
| Total current liabilities | |||||||||
| Forward purchase agreement liability | |||||||||
| Deferred underwriting fee | |||||||||
| Deferred underwriting fee | |||||||||
| Convertible notes, net of debt discount | |||||||||
| Nonrelated party | |||||||||
| Related party | |||||||||
| Accrued interest on convertible notes | |||||||||
| Nonrelated party | |||||||||
| Related party | |||||||||
| Operating lease liabilities, noncurrent | |||||||||
| Finance lease liabilities, noncurrent | |||||||||
| Deferred tax liabilities, net | |||||||||
| Total liabilities | |||||||||
| Class A ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of $10.55 and $10.23 per share at September 30, 2025 and December 31, 2024, respectively | |||||||||
| Stockholders' Equity | |||||||||
| Common shares, $0.0001 par value; 500,000,000 authorized shares; 82,718,567 and 81,771,422 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Class B Ordinary Shares | |||||||||
| Total common shares, $0.0001 par value; 500,000,000 authorized shares; 82,718,567 and 81,771,422 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Exchangeable shares, $0.0001 par value; 23,216,687 and 24,011,017 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Additional paid-in-capital | |||||||||
| Accumulated deficit | |||||||||
| Accumulated other comprehensive income | |||||||||
| Total stockholders' equity (deficit) | |||||||||
| Total stockholders' equity | |||||||||
| Total liabilities and stockholders' equity |
Loading...
